Undervalued Stocks Based On Cash Flows

Results

698

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

698 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
BETCO
SEK 122.602.0%-7.5%SEK 7.1bSEK 167.9723.931.0%n/aConsumer Services
SDIP B
SEK 250.603.0%20.2%SEK 9.5bSEK 290.201.958.6%n/aCommercial Services
CTEC
UK£2.093.4%-26.9%UK£4.1bUK£2.9831.320.0%2.6%Healthcare
11B
zł138.90-4.2%-40.9%zł335.7mzł188.5748.456.8%n/aMedia
VIRI
€93.90-14.3%45.7%€675.1m€160.108.923.3%n/aEnergy
2542
NT$45.600.3%17.1%NT$96.0bNT$47.0014.240.1%8.8%Real Estate Management and Development
BSGR
€5.850%40.6%€492.4m€5.9615.227.7%3.2%Retail
DEZ
€9.937.7%42.0%€1.5b€12.9417.828.5%1.8%Capital Goods
BONEX
SEK 218.20-3.2%-17.6%SEK 14.4bSEK 373.8377.633.8%n/aPharmaceuticals & Biotech
TE
€36.345.6%4.8%€6.4b€44.2418.413.8%2.8%Energy
IDX
AU$2.073.0%-9.2%AU$771.1mAU$3.1455.032.6%3.5%Healthcare
SANOMA
€9.05-0.5%-8.8%€1.5b€12.14100.032.6%4.6%Media
KAP
US$72.105.1%66.5%US$9.0tUS$87.1417.114.6%3.7%Energy
EMG
UK£2.964.3%70.2%UK£3.3bUK£3.0725.326.5%4.3%Diversified Financials
MRK
US$115.17-3.7%47.1%US$283.8bUS$129.7431.821.2%3.0%Pharmaceuticals & Biotech
NCC B
SEK 193.709.0%1.8%SEK 18.9bSEK 220.00205.948.7%4.6%Capital Goods
6266
JP¥4,145.0018.4%101.9%JP¥60.8bJP¥4,000.0021.524.8%0.8%Semiconductors
1180
HK$0.7212.5%-18.2%HK$831.2mHK$1.3069.379.9%13.9%Consumer Services
LAZ
US$44.90-5.1%4.5%US$4.3bUS$52.0016.431.3%4.5%Diversified Financials
PCR
zł66.30-1.5%-4.5%zł1.3bzł82.4121.820.4%7.6%Materials
300118
CN¥13.751.9%54.0%CN¥15.9bCN¥23.251.3107.5%0%Semiconductors
4776
JP¥2,284.00-2.4%-35.8%JP¥106.2bJP¥4,000.0014.112.9%2.2%Software
NREST
SEK 255.50-6.4%53.5%SEK 3.3bSEK 345.0016.212.3%3.3%Consumer Services
MSAB B
SEK 69.20-7.7%27.2%SEK 1.3bSEK 78.2527.729.3%2.3%Software
Page 1 of 20